Pancreatitis – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Pancreatitis – Drugs In Development, 2024 report and make more profitable business decisions.
Pancreatitis is an inflammation of the pancreas. Symptoms include nausea, vomiting, tenderness when touching the abdomen, weight loss, and upper abdominal pain. Predisposing factors include alcoholism, smoking, family history of pancreatitis, infection, injury to the abdomen, and pancreatic cancer. Treatment includes antibiotics and medication to relieve pain.
The Pancreatitis drugs in development market research report provide comprehensive information on the therapeutics under development for Pancreatitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pancreatitis and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Pancreatitis | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 42 molecules, with 37 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Pancreatitis therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Pancreatitis pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Pancreatitis treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
AcelRx Pharmaceuticals IncAriel Precision Medicine Inc
Baylor Scott & White Health
Beijing GeneCradle Technology Co Ltd
Bessor Pharma LLC
CalciMedica Inc
Centeer BioTherapeutics Ltd Co
ChemIcare Srl
Cisen Pharmaceutical Co Ltd
Cypralis Ltd
D&D Pharmatech Co Ltd
Daewoong Pharmaceutical Co Ltd
DiaMedica Therapeutics Inc
Duke University
Evive Biotech
Georgetown University
GNT Pharma Co Ltd
GSK plc
Healx Ltd
HighTide Therapeutics Inc
JD Bioscience Inc
Kynos Therapeutics Ltd
Lamassu Pharma LLC
LipimetiX Development Inc
Mallinckrodt Plc
OM Pharma Ltd
Panbela Therapeutics Inc
Path BioAnalytics Inc
PNB Vesper Life Science Pvt Ltd
Samsung Bioepis Co Ltd
SCM lifescience Co Ltd
Shionogi & Co Ltd
University Hospital Geneva
University of Barcelona
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Pancreatitis reports